Caribou Biosciences Inc. (NASDAQ:CRBU) shares skyrocketed 100% on Monday after the company released promising Phase 1 ...
And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've ...
23h
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130%
Intellia Therapeutics also has fans on Wall Street. The company's current average price target of $32.3 (according to Yahoo! Finance) implies a significant 131% upside from its current levels. And ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback